Relevant bibliographies by topics / Targeted nanotherapy

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters
  4. Conference papers

Academic literature on the topic 'Targeted nanotherapy'

Author: Grafiati
Published: 22 June 2024
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Targeted nanotherapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Targeted nanotherapy"

1

Kim, Gloria J., and Shuming Nie. "Targeted cancer nanotherapy." Materials Today 8, no. 8 (2005): 28–33. http://dx.doi.org/10.1016/s1369-7021(05)71034-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mathew, Anila, Toru Maekawa, and D. Sakthikumar. "Aptamers in Targeted Nanotherapy." Current Topics in Medicinal Chemistry 15, no. 12 (2015): 1102–14. http://dx.doi.org/10.2174/1568026615666150413153525.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zhu, Peng, Carl Atkinson, Suraj Dixit, et al. "Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo." RSC Advances 8, no. 46 (2018): 25909–19. http://dx.doi.org/10.1039/c8ra01555d.

Full text
Abstract:
(a) Rapamycin nanotherapeutic pre-treatment improves tracheal allograft outcome after transplantation. (b) Nanotherapy reduces aortic allograft vasculopathy. (c) Dose dependency of the nanotherapy in aortic interposition allografts.
APA, Harvard, Vancouver, ISO, and other styles
4

Crintea, Andreea, Anne-Marie Constantin, Alexandru C. Motofelea, et al. "Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer." Journal of Functional Biomaterials 14, no. 9 (2023): 466. http://dx.doi.org/10.3390/jfb14090466.

Full text
Abstract:
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide. Despite advances in treatment, the prognosis remains poor, highlighting the need for novel therapeutic strategies. The present review explores the potential of targeted epidermal growth factor receptor (EGFR) nanotherapy as an alternative treatment for NSCLC, showing that EGFR-targeted nanoparticles are efficiently taken up by NSCLC cells, leading to a significant reduction in tumor growth in mouse models. Consequently, we suggest that targeted EGFR nanotherapy could be an innovative treatment str
APA, Harvard, Vancouver, ISO, and other styles
5

Narayanan, Sreeja, N. S. Binulal, Ullas Mony, Koyakutty Manzoor, Shantikumar Nair, and Deepthy Menon. "Folate targeted polymeric ‘green’ nanotherapy for cancer." Nanotechnology 21, no. 28 (2010): 285107. http://dx.doi.org/10.1088/0957-4484/21/28/285107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Katsogiannou, M., L. Peng, C. V. Catapano, and P. Rocchi. "Active-Targeted Nanotherapy Strategies for Prostate Cancer." Current Cancer Drug Targets 11, no. 8 (2011): 954–65. http://dx.doi.org/10.2174/156800911797264770.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Metcalfe, Su M., and Tarek M. Fahmy. "Targeted nanotherapy for induction of therapeutic immune responses." Trends in Molecular Medicine 18, no. 2 (2012): 72–80. http://dx.doi.org/10.1016/j.molmed.2011.11.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hu, Xiankang, and Jianxiang Zhang. "Yeast capsules for targeted delivery: the future of nanotherapy?" Nanomedicine 12, no. 9 (2017): 955–57. http://dx.doi.org/10.2217/nnm-2017-0059.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rapoport, N. Ya, K. H. Nam, Z. Gao, and A. Kennedy. "Application of ultrasound for targeted nanotherapy of malignant tumors." Acoustical Physics 55, no. 4-5 (2009): 594–601. http://dx.doi.org/10.1134/s1063771009040162.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Soodgupta, Deepti, Dipanjan Pan, Grace Hu, et al. "Preclinical Development Of a Nanomedicne Approach For Multiple Myeloma Targeting The Myc Oncoprotein." Blood 122, no. 21 (2013): 4228. http://dx.doi.org/10.1182/blood.v122.21.4228.4228.

Full text
Abstract:
Abstract Purpose This study investigated alpha 4 beta 1/ Very Late Antigen-4 (α4β1/ VLA-4)-integrin targeted nanotherapy approach to deliver a new lipase-labile prodrug. Experimental Design A phospholipid-based MYC-MAX inhibitor prodrug (MI1-PD) was synthesized, and its inherent anti-proliferate potency was compared to the lipid-free compound (MI1) using mouse multiple myeloma (MM) cell line (5TGM1). VLA-4-targeted perfluorocarbon (PFC) nanoparticles binding to 5TGM1 cells was measured and compared to biomarker expression assessed with flow cytometry using antibodies. The efficacy of MI1-PD in
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Targeted nanotherapy"

1

Sibuyi, Nicole Remaliah Samantha. "Development of a receptor targeted nanotherapy using a proapoptotic peptide." University of the Western Cape, 2015. http://hdl.handle.net/11394/4708.

Full text
Abstract:
Philosophiae Doctor - PhD<br>The prevalence of obesity amongst South Africans is alarming, with more than 29% of men and 56% of women considered to be obese. Angiogenesis, a process for development of new blood vessels play a major role in growth and survival of the adipose tissues. Pharmacological inhibitors of angiogenesis are therefore a sensible strategy to reduce excess body weight. Current anti-obesity drugs have limitations because of their lack of selectivity and specificity, which lead to undesirable side effects and reduced drug efficacy. Future anti-obesity therapeutic strategies sh
APA, Harvard, Vancouver, ISO, and other styles
2

Webster, Carl. "Development of a novel targeted nanotherapy for the treatment of melanoma." Thesis, University of East Anglia, 2016. https://ueaeprints.uea.ac.uk/62677/.

Full text
Abstract:
Nanoparticles have been utilised in a wide range of applications and they provide unique advantages as drug delivery carriers and imaging agents in biomedicine. In particular, nanoparticles have been employed as therapeutic systems in oncology to overcome the limitations of conventional chemotherapeutics. Melanoma is the cancer of pigment-producing cells in the basal layer of the epidermis. Once metastasised, melanoma is highly aggressive and notoriously difficult to treat with the currently available therapies. In order to improve the therapeutic options available for the treatment of melanom
APA, Harvard, Vancouver, ISO, and other styles
3

Journaux-Duclos, Justine. "Ciblage thérapeutique de l'adénocarcinome pancréatique par hyperthermie magnétique ou ablation magnéto-mécanique." Electronic Thesis or Diss., Toulouse 3, 2023. http://www.theses.fr/2023TOU30360.

Full text
Abstract:
Grâce à leurs propriétés physico-chimiques et leur biocompatibilité les nanoparticules magnétiques d'oxyde de fer (SPION) offrent de nombreux avantages. Elles répondent à l'application de champs magnétiques en libérant de l'énergie thermique en réponse à l'application d'un champ magnétique alternatif à haute fréquence (AMF), ou générant des forces mécaniques exposées à des champs magnétiques rotatifs à basse fréquence (RMF). Des essais cliniques utilisant le principe de l'hyperthermie magnétique ont été menés sur le glioblastome et le cancer de la prostate en association avec de la radiothérap
APA, Harvard, Vancouver, ISO, and other styles
4

Gouveia, Virgínia Adorinda Moura. "Target-to-treat nanotherapy for rheumatoid arthritis." Doctoral thesis, 2020. https://hdl.handle.net/10216/128621.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gouveia, Virgínia Adorinda Moura. "Target-to-treat nanotherapy for rheumatoid arthritis." Tese, 2020. https://hdl.handle.net/10216/128621.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Targeted nanotherapy"

1

Sahu, Prashant, Sushil K. Kashaw, Varsha Kashaw, and Arun K. Iyer. "Functional Nanogels and Hydrogels: A Multipronged Nanotherapy in Drug Delivery and Imaging." In Multifunctional And Targeted Theranostic Nanomedicines. Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-99-0538-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ueoka, Ryuichi, Yoko Matsumoto, Hideaki Ichihara, and Yuji Komizu. "Membrane-Targeted Nanotherapy with Hybrid Liposomes for Cancer Cells Leading to Apoptosis." In Molecular Science of Fluctuations Toward Biological Functions. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55840-8_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Derakhshandeh, Katayoun, and Abbas Hemmati Azandaryani. "Active-targeted Nanotherapy as Smart Cancer Treatment." In Smart Drug Delivery System. InTech, 2016. http://dx.doi.org/10.5772/61791.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Prabhakar, Pranav Kumar. "Targeted Nanotherapies for Diabetic Complications." In Cutting-Edge Applications of Nanomaterials in Biomedical Sciences. IGI Global, 2023. http://dx.doi.org/10.4018/979-8-3693-0448-8.ch006.

Full text
Abstract:
Diabetes mellitus is a chronic metabolic disorder characterized by impaired glucose regulation, which leads to various complications affecting multiple organs and systems. This chapter discusses various types of nanomaterials, such as liposomes, polymeric nanoparticles, dendrimers, and carbon-based nanomaterials, and their potential for encapsulating and delivering therapeutic agents to specific sites affected by diabetic complications. The advantages of nanomaterial-based drug delivery, including enhanced drug stability, prolonged circulation time, and improved targeting efficiency, are highl
APA, Harvard, Vancouver, ISO, and other styles
5

Melia, F., Tanveer A. Tabish, and M. Z. I. Pranjol. "Targeted Gold Nanotherapy for the Attenuation of Chemotherapy-associated Cardiotoxicity." In Cardiovascular Nanomedicine. Royal Society of Chemistry, 2024. http://dx.doi.org/10.1039/9781837671113-00197.

Full text
Abstract:
Cancer is the second leading cause of death among noncommunicable diseases worldwide. Despite the improvements in prognosis within the last few decades, the quality of life and life expectancy of patients treated with chemotherapy are endangered by the development of cardiotoxic adverse effects. The occurrence of life-threatening cardiovascular complications in cancer patients hinders the benefits of cancer therapy, restricts treatment options and limits the testing of new chemotherapeutic drugs. Certainly, novel therapeutic strategies, such as nanomedicine, are required to minimise cardiotoxi
APA, Harvard, Vancouver, ISO, and other styles
6

Khusro, Ameer, Chirom Aarti, Mona M. M. Y. Elghandour, and Abdelfattah Z. M. Salem. "Potential targets in quest for new antitubercular drugs: Implications of computational approaches for end-TB strategy." In A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy. Elsevier, 2021. http://dx.doi.org/10.1016/b978-0-12-819985-5.00005-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Abou-Jaoude, Mathieu, Rakesh Kumar Sharma, Aditya Nair, et al. "Nanotherapy approach to target ZIKA virus in microglia: A case study." In Nanotechnological Applications in Virology. Elsevier, 2022. http://dx.doi.org/10.1016/b978-0-323-99596-2.00013-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Targeted nanotherapy"

1

Bonizzi, Arianna, Marta Truffi, Leopoldo Sitia, et al. "Development FAP-Targeted Nanotherapy against Cancer-Associated Fibroblasts." In The 7th World Congress on Recent Advances in Nanotechnology. Avestia Publishing, 2022. http://dx.doi.org/10.11159/nddte22.141.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mriouah, Jihane, Rae Lynn Nesbitt, Susan Richter, et al. "Abstract 5143: Fusogenic targeted liposomes: novel nanotherapy for specific treatment of prostate cancer." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-5143.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Baldwin, Paige, Rajiv Kumar, and Srinivas Sridhar. "Abstract 3715: Targeted nanotherapy using the PARP inhibitor talazoparib for breast cancer treatment." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-3715.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Heller, Daniel A., Edgar Jaimes, Ryan Williams, and Janki Shah. "Abstract 2032: Renal tubule-targeted supportive care nanotherapy for cisplatin-induced acute kidney injury." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-2032.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Targeted nanotherapy' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography